Rib-X Pharmaceuticals

#	Item
1	New Drugs 4 Bad Bugs (ND4BB) Topic 5 : Clinical Development of antibacterial agents for Gram-negative antibiotic resistant pathogens EFPIA partners : AstraZeneca, Basilea, Cubist, GSK Dr Seamus O’Brien AstraZeneca Add to Reading List Source URL: www.imi.europa.eu Language: English - Date: 2013-07-09 11:31:07 Health Antibiotic resistance Antibacterial New Delhi metallo-beta-lactamase 1 Carbapenem Drug resistance Rib-X Pharmaceuticals Phage therapy Antibiotics Medicine Biology
2	PDF Document Add to Reading List Source URL: www.toku-e.com Language: English - Date: 2012-05-15 13:21:06 Pseudomonadales Moraxellaceae Bacterial diseases Acinetobacter Pseudomonas aeruginosa Pseudomonas Burkholderia cepacia complex Rib-X Pharmaceuticals Bacteria Microbiology Gram-negative bacteria
3	PDF Document Add to Reading List Source URL: aac.asm.org Language: English Chemistry Ribosomal RNA Organofluorides Ribozymes Gene expression Linezolid 2-Oxazolidone Rib-X Pharmaceuticals 23S ribosomal RNA Biology RNA Protein biosynthesis